1.	Guieu R, Devaux C, Henry H, Bechis G, Pouget J, Mallet D, Sampieri F, Juin M, Gola R, Rochat H. Adenosine and migraine. Can J Neurol Sci. 1998 Feb;25(1):55-8. Abstract
2.	Sawynok J. Adenosine receptor activation and nociception. Eur J Pharmacol. 1998 Apr 17;347(1):1-11. Abstract
3.	Burnstock G. A unifying purinergic hypothesis for the initiation of pain. Lancet. 1996 Jun 8;347(9015):1604-5. Abstract
4.	Update on Headache by Robert Baldor, MD. Medscape
5.	Medscape
6.	ACHEnet
7.	Scher AI, Stewart WF, Lipton RB. Caffeine as a risk factor for chronic daily headache: a population-based study. Neurology. 2004 Dec 14;63(11):2022-7. Abstract
8.	Griffiths RR, Evans SM, Heishman SJ, Preston KL, Sannerud CA, Wolf B, Woodson PP. Low-dose caffeine physical dependence in humans. J Pharmacol Exp Ther. 1990 Dec;255(3):1123-32. Abstract
9.	Frary CD, Johnson RK, Wang MQ. Food sources and intakes of caffeine in the diets of persons in the United States. J Am Diet Assoc. 2005 Jan;105(1):110-3. Abstract
10.	Gilbert RM. Caffeine consumption. Prog Clin Biol Res. 1984;158:185-213. Abstract
11.	Ward N, Whitney C, Avery D, Dunner D. The analgesic effects of caffeine in headache. Pain. 1991 Feb;44(2):151-5. Abstract
12.	Yoovathaworn KC, Sriwatanakul K, Thithapandha A. Influence of caffeine on aspirin pharmacokinetics. Eur J Drug Metab Pharmacokinet. 1986 Jan-Mar;11(1):71-6. Abstract
13.	Castaneda-Hernandez G, Castillo-Mendez MS, Lopez-Munoz FJ, Granados-Soto V, Flores-Murrieta FJ. Potentiation by caffeine of the analgesic effect of aspirin in the pain-induced functional impairment model in the rat. Can J Physiol Pharmacol. 1994 Oct;72(10):112731. Abstract
14.	Engelhardt G, Mauz AB, Pairet M. Role of caffeine in combined analgesic drugs from the point of view of experimental pharmacology. Arzneimittelforschung. 1997 Aug;47(8):917-27. Abstract
15.	Godfrey L, Yan L, Clarke GD, Ledent C, Kitchen I, Hourani SM. Modulation of paracetamol antinociception by caffeine and by selective adenosine A2 receptor antagonists in mice. Eur J Pharmacol. 2006 Feb 15;531(1-3):80-6. Epub 2006 Jan 30. Abstract
16.	Sawynok J. Pharmacological rationale for the clinical use of caffeine. Drugs. 1995 Jan;49(1):37-50. Abstract
17.	Schoonman G, Sandor P, Agosti R, Siccoli M, Bartsch P, Ferrari M, Baumgartner R. Normobaric hypoxia and nitroglycerin as trigger factors for migraine. Cephalalgia. 2006 Jul;26(7):816-9. Abstract
18.	Shi D, Daly JW. Chronic effects of xanthines on levels of central receptors in mice. Cell Mol Neurobiol. 1999 Dec;19(6):719-32. Abstract
19.	Varani K, Portaluppi F, Gessi S, Merighi S, Vincenzi F, Cattabriga E, Dalpiaz A, Bortolotti F, Belardinelli L, Borea PA. Caffeine intake induces an alteration in human neutrophil A2A adenosine receptors. Cell Mol Life Sci. 2005 Oct;62(19-20):2350-8. Abstract
20.	Kuper H, Titus-Ernstoff L, Harlow BL, Cramer DW. Population based study of coffee, alcohol and tobacco use and risk of ovarian cancer. Int J Cancer. 2000 Oct 15;88(2):313-8. Abstract
21.	Hughes JR, Oliveto AH. A systematic survey of caffeine intake in Vermont. Exp Clin Psychopharmacol. 1997 Nov;5(4):393-8. Abstract
22.	Talcott GW, Poston WS 2nd, Haddock CK. Co-occurrent use of cigarettes, alcohol, and caffeine in a retired military population. Mil Med. 1998 Mar;163(3):133-8. Abstract
23.	Hettema JM, Corey LA, Kendler KS.A multivariate genetic analysis of the use of tobacco, alcohol, and caffeine in a population based sample of male and female twins. Drug Alcohol Depend. 1999 Nov 1;57(1):69-78. Abstract
24.	Weinmann S, Siscovick DS, Raghunathan TE, Arbogast P, Smith H, Bovbjerg VE, Cobb LA, Psaty BM. Caffeine intake in relation to the risk of primary cardiac arrest. Epidemiology. 1997 Sep;8(5):505-8. Abstract
25.	Collins RL, Gollnisch G, Morsheimer ET. Substance use among a regional sample of female nurses. Drug Alcohol Depend. 1999 Jun 1;55(1-2):145-55. Abstract
26.	Nathan PA, Keniston RC, Lockwood RS, Meadows KD. Tobacco, caffeine, alcohol, and carpal tunnel syndrome in American industry. A cross-sectional study of 1464 workers. J Occup Environ Med. 1996 Mar;38(3):290-8. Abstract
27.	Mills JL, Holmes LB, Aarons JH, Simpson JL, Brown ZA, Jovanovic-Peterson LG, Conley MR, Graubard BI, Knopp RH, Metzger BE. Moderate caffeine use and the risk of spontaneous abortion and intrauterine growth retardation. JAMA. 1993 Feb 3;269(5):593-7. Abstract
28.	Tomany SC, Klein R, Klein BE. The relation of coffee and caffeine to the 5-year incidence of early age-related maculopathy: the Beaver Dam Eye Study. Am J Ophthalmol. 2001 Aug;132(2):271-3. Abstract
29.	Curtis KM, Savitz DA, Arbuckle TE. Effects of cigarette smoking, caffeine consumption, and alcohol intake on fecundability. Am J Epidemiol. 1997 Jul 1;146(1):32-41. Abstract
30.	Morgan KJ, Stults VJ, Zabik ME. Amount and dietary sources of caffeine and saccharin intake by individuals ages 5 to 18 years. Regul Toxicol Pharmacol. 1982 Dec;2(4):296-307. Abstract
31.	Frary CD, Johnson RK, Wang MQ. Food sources and intakes of caffeine in the diets of persons in the United States. J Am Diet Assoc. 2005 Jan;105(1):110-3. Abstract
32.	Rasmussen BK, Jensen R, Schroll M, Olesen J. Epidemiology of headache in a general population—a prevalence study. J Clin Epidemiol 1991;44.1147-57. Abstract
33.	Ho KH, Ong BK, Lee SC. Headache and self-assessed depression scores in Singapore University undergraduates. Headache. 1997 Jan;37(1):26-30. Abstract
34.	Muniz R, Macia C, Montiel I, Gonzalez O, Martin R, Asensio M, Matias-Guiu J. [Prevalence of migraine in the medical student population as determined by means of the 'Alcoi 1992' questionnaire] Rev Neurol. 1995 Jul-Aug;23(122):870-3. Abstract
35.	Deleu D, Khan MA, Humaidan H, Al Mantheri Z, Al Hashami S. Prevalence and clinical characteristics of headache in medical students in Oman. Headache. 2001 Sep;41(8):798-804. Abstract
36.	Gobel H, Petersen-Braun M, Soyka D. The epidemiology of headache in Germany: a nationwide survey of a representative sample on the basis of the headache classification of the International Headache Society. Cephalalgia. 1994 Apr;14(2):77. Abstract
37.	Merikangas KR, Whitaker AE, Isler H, Angst J. The Zurich Study: XXIII. Epidemiology of headache syndromes in the Zurich cohort study of young adults. Eur Arch Psychiatry Clin Neurosci. 1994;244(3):145-52. Abstract
38.	Russell MB, Rasmussen BK, Thorvaldsen P, Olesen J. [Prevalence and sex distribution of different forms of migraine] Ugeskr Laeger. 1996 Mar 4;158(10):1369-72. Danish. Abstract
39.	Steiner TJ, Scher AI, Stewart WF, Kolodner K, Liberman J, Lipton RB. The prevalence and disability burden of adult migraine in England and their relationships to age, gender and ethnicity. Cephalalgia. 2003 Sep;23(7):519-27. Abstract
40.	O'Brien B, Goeree R, Streiner D. Prevalence of migraine headache in Canada: a population-based survey. Int J Epidemiol. 1994 Oct;23(5):1020-6. Abstract
41.	Auray JP. [Socio-economic impact of migraine and headaches in France] CNS Drugs. 2006;20 Spec no.1:37-46. French Abstract
42.	Stewart WF, Lipton RB, Celentano DD, Reed ML. Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. JAMA. 1992 Jan 1;267(1):64-9. Abstract
43.	Loder E. What is the evolutionary advantage of migraine? Cephalalgia. 2003 Nov;23(9):931; author reply 931. Article information
44.	Salazar-Martinez E, Willett WC, Ascherio A, Manson JE, Michael F. Leitzmann MF, Meir J. Stampfer MJ, Hu FB. Coffee Consumption and Risk for Type 2 Diabetes Mellitus. Ann Intern Med.2004;140:18. Abstract
45.	Andersen LF, Jacobs DR Jr, Carlsen MH, Blomhoff R. Consumption of coffee is associated with reduced risk of death attributed to inflammatory and cardiovascular diseases in the Iowa Women's Health Study. Am J Clin Nutr. 2006 May;83(5):1039-46. Abstract
46.	Cady R, Schreiber C, Farmer K, Sheftell F. Primary headaches: a convergence hypothesis. Headache. 2002 Mar;42(3):204-16. Abstract
47.	Silberstein SD, Niknam R, Rozen TD, Young WB. Cluster headache with aura. Neurology. 2000 Jan 11;54(1):219-21. Abstract
48.	Krymchantowski AV. Aura with non-migraine headache. Curr Pain Headache Rep. 2005 Aug;9(4):264-7. Abstract
49.	Fuad F, Jones NS. Paroxysmal hemicrania and cluster headache: two discrete entities or is there an overlap? Clin Otolaryngol Allied Sci. 2002 Dec;27(6):472-9. Abstract
50.	Sanin LC, Mathew NT, Bellmeyer LR, Ali S. The International Headache Society (IHS) headache classification as applied to a headache clinic population. Cephalalgia. 1994 Dec;14(6):443-6. Abstract
51.	Turkdogan D, Cagirici S, Soylemez D, Sur H, Bilge C, Turk U. Characteristic and overlapping features of migraine and tension-type headache. Headache. 2006 Mar;46(3):461-8. Abstract
52.	Nyholt D R Gillespie NA, Heath, AC, Merikangas, KR, Duffy DL, Martin NG. Latent class analysis does not support migraine with aura and migraine without aura as separate entities. Genetic Epidemiology. 2004:26, 231. Abstract
53.	Ligthart L, Boomsma DI, Martin NG, Stubbe JH, Nyholt DR. Migraine with aura and migraine without aura are not distinct entities: further evidence from a large Dutch population study. 2006 Feb;9(1):54-63. Abstract
54.	Lipton RB, Stewart WF, Cady R, Hall C, O'Quinn S, Kuhn T, Gutterman D. Sumatriptan for the range of headaches in migraine sufferers: results of the Spectrum Study. Headache. 2000 NovDec;40(10):783-91. Abstract
55.	Sanchez-del-Rio M, Reuter U. Migraine aura: new information on underlying mechanisms. Curr Opin Neurol. 2004 Jun;17(3):289-93. Abstract
56.	Gervil M, Ulrich V, Kaprio J, Olesen J, Russell MB. The relative role of genetic and environmental factors in migraine without aura. Neurology. 1999 Sep 22;53(5):995-9. Abstract
57.	Terwindt GM, Ophoff RA, Haan J, Vergouwe MN, van Eijk R, Frants RR, Ferrari MD. Variable clinical expression of mutations in the P/Q-type calcium channel gene in familial hemiplegic migraine. Dutch Migraine Genetics Research Group. Neurology. 1998 Apr;50(4):1105-10. Abstract
58.	Schurks M, Kurth T, Geissler I, Tessmann G, Diener HC, Rosskopf D. Cluster headache is associated with the G1246A polymorphism in the hypocretin receptor 2 gene. Neurology 2006;66:1917-1919. Abstract
59.	Butler MA, Iwasaki M, Guengerich FP, Kadlubar FF. Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. Proc Natl Acad Sci U S A. 1989 Oct;86(20):7696-700. Abstract
60.	Vincent-Viry M, Pontes ZB, Gueguen R, Galteau MM, Siest G. Segregation analyses of four urinary caffeine metabolite ratios implicated in the determination of human acetylation phenotypes. Genet Epidemiol 1994;11(2):115-129 Abstract
61.	Chevalier D, Cauffiez C, Allorge D, Lo-Guidice JM, Lhermitte M, Lafitte JJ, Broly F. Five novel natural allelic variants — 951A>C, 1042G>A (D348N), 1156A>T (I386F), 1217G>A (C406Y) and 1291C>T (C431Y) — of the human CYP1A2 gene in a French Caucasian population. Hum Mutat. 2001 Apr;17(4):355-6. Abstract
62.	Butler MA, Lang NP, Young JF, Caporaso NE, Vineis P, Hayes RB, Teitel CH, Massengill JP, Lawsen MF, Kadlubar FF. Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites. Pharmacogenetics. 1992 Jun;2(3):116-27. Abstract
63.	Somani SM, Gupta P. Caffeine: a new look at an age-old drug. Int J Clin Pharmacol Ther Toxicol. 1988 Nov;26(11):521-33. Abstract
64.	Golding J. Reproduction and caffeine consumption: a literature review. Early Hum Dev. 1995 Aug 30;43(1):1-14. Abstract
65.	Kendler KS, Prescott CA. Am J Psychiatry. Caffeine intake, tolerance, and withdrawal in women: a population-based twin study. 1999 Feb;156(2):223-8. Abstract
66.	Marangos PJ, Boulenger JP, Patel J. Effects of chronic caffeine on brain adenosine receptors: regional and ontogenetic studies. Life Sci. 1984 Feb 27;34(9):899-907. Abstract
67.	Aden U, Herlenius E, Tang LQ, Fredholm BB. Maternal caffeine intake has minor effects on adenosine receptor ontogeny in the rat brain. Pediatr Res. 2000 Aug;48(2):177-83. Abstract
68.	Russell MB, Iselius L, Olesen J. Migraine without aura and migraine with aura are inherited disorders. Cephalalgia. 1996 Aug;16(5):3059. Abstract
69.	Zaigler M, Rietbrock S, Szymanski J, Dericks-Tan JS, Staib AH, Fuhr U. Variation of CYP1A2-dependent caffeine metabolism during menstrual cycle in healthy women. Int J Clin Pharmacol Ther 2000;38(5):235-244. Abstract
70.	Gilbert RM. The Methylxanthine Beverages and Foods: Chemistry, Consumption, and Health Effects (Progress in Clinical and Biological Research, vol 158) Spiller GA (ed) ISBN 0-8451-5008-1 New York: Alan R Liss 1984.
71.	Tanaka E. In vivo age-related changes in hepatic drug-oxidizing capacity in humans. J Clin Pharm Ther. 1998 Aug;23(4):247-55. Abstract
72.	Yeung SM, Perez-Reyes E, Cooper DM. Hydrodynamic properties of adenosine Ri receptors solubilized from rat cerebral-cortical membranes. Biochem J 1987;248(3):635-642. Abstract Complete article
73.	Fragoso YD, Carvalho R, Ferrero F, Lourenco DM, Paulino ER. Crying as a precipitating factor for migraine and tension-type headache. Sao Paulo Med J. 2003 Jan 2;121(1):31-3. Abstract
74.	Blau JN. Migraine triggers: practice and theory. Pathol Biol (Paris). 1992 Apr;40(4):367-72. Abstract
75.	Buchholz D. Heal your headache: the 1-2-3 program for taking charge of your pain. Workman, 2002. Amazon
76.	Holzhammer J, Wober C. [Alimentary trigger factors that provoke migraine and tension-type headache] Schmerz. 2006 Apr;20(2):1519. Abstract
77.	Moffett AM, Swash M, Scott DF. Effect of chocolate in migraine: a double-blind study. J Neurol Neurosurg Psychiatry. 1974 Apr;37(4):445-8. Abstract
78.	Gibb CM, Davies PT, Glover V, Steiner TJ, Clifford Rose F, Sandler M. Chocolate is a migraine-provoking agent. Cephalalgia. 1991 May;11(2):93-5. Abstract
79.	Marcus DA, Scharff L, Turk D, Gourley LM. A double-blind provocative study of chocolate as a trigger of headache. Cephalalgia. 1997 Dec;17(8):855-62. Abstract
80.	Moffett A, Swash M, Scott DF. Effect of tyramine in migraine: a double-blind study. J Neurol Neurosurg Psychiatry. 1972 Aug;35(4):496-9. Article info
81.	Federation of American Societies for Experimental Biology (FASEB). Analysis of Adverse Reactions to Monosodium Glutamate (MSG). Prepared by the Life Sciences Research Office, FASEB, for the Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administration. Bethesda, Maryland: FASEB, 1995.
82.	Yang WH, Drouin MA, Herbert M, Mao Y, Karsh J. The monosodium glutamate symptom complex: assessment in a double-blind, placebo-controlled, randomized study. J Allergy Clin Immunol. 1997 Jun;99(6 Pt 1):757-62. Abstract
83.	Geha RS, Beiser A, Ren C, Patterson R, Greenberger PA, Grammer LC, Ditto AM, Harris KE, Shaughnessy MA, Yarnold PR, Corren J, Saxon A. Multicenter, double-blind, placebo-controlled, multiplechallenge evaluation of reported reactions to monosodium glutamate. J Allergy Clin Immunol. 2000 Nov;106(5):973-80. Abstract
84.	Lipton RB, Newman LC, Cohen JS, Solomon S. Aspartame as a dietary trigger of headache. Headache. 1989 Feb;29(2):90-2. Abstract
85.	Schiffman SS, Buckley CE 3rd, Sampson HA, Massey EW, Baraniuk JN, Follett JV, Warwick ZS. Aspartame and susceptibility to headache. N Engl J Med. 1987 Nov 5;317(19):1181-5. Abstract
86.	Lapierre KA, Greenblatt DJ, Goddard JE, Harmatz JS, Shader RI. The neuropsychiatric effects of aspartame in normal volunteers. J Clin Pharmacol. 1990 May;30(5):454-60. Abstract
87.	Van den Eeden SK, Koepsell TD, Longstreth WT Jr, van Belle G, Daling JR, McKnight B. Aspartame ingestion and headaches: a randomized crossover trial. Neurology. 1994 Oct;44(10):1787-93. Abstract
88.	Lampe JW, King IB, Li S, Grate MT, Barale KV, Chen C, Feng Z, Potter JD. Brassica vegetables increase and apiaceous vegetables decrease cytochrome P450 1A2 activity in humans: changes in caffeine metabolite ratios in response to controlled vegetable diets. Carcinogenesis. 2000 Jun;21(6):1157-62. Abstract
89.	McDanell RE, Henderson LA, Russell K, McLean AE. The effect of brassica vegetable consumption on caffeine metabolism in humans. Hum Exp Toxicol. 1992 May;11(3):167-72. Abstract
90.	Cancino-Badias L, Reyes RE, Nosti R, Perez I, Dorado V, Caballero S, Soria A, Camacho-Carranza R, Escobar D, Espinosa-Aguirre JJ. Modulation of rat liver cytochrome P450 by protein restriction assessed by biochemical and bacterial mutagenicity methods [corrected]. Mutagenesis. 2003 Mar;18(2):217. Abstract
91.	Fontana RJ, Lown KS, Paine MF, Fortlage L, Santella RM, Felton JS, Knize MG, Greenberg A, Watkins PB. Effects of a chargrilled meat diet on expression of CYP3A, CYP1A, and P-glycoprotein levels in healthy volunteers. Gastroenterology. 1999 Jul;117(1):89-98. Abstract
92.	Xiao Dong S, Zhi Ping Z, Zhong Xiao W, Chong Shu C, Fattore C, Gatti G, D'urso S, Perucca E. Possible enhancement of the first-pass metabolism of phenacetin by ingestion of grape juice in Chinese subjects. Br J Clin Pharmacol. 1999 Oct;48(4):638-40. Abstract
93.	Fuhr U, Klittich K, Staib AH. Inhibitory effect of grapefruit juice and its bitter principal, naringenin, on CYP1A2 dependent metabolism of caffeine in man. Br J Clin Pharmacol. 1993 Apr;35(4):431-6. Abstract
94.	Ballard TL, Halaweish FT, Stevermer CL, Agrawal P, Vukovich MD. Naringin does not alter caffeine pharmacokinetics, energy expenditure, or cardiovascular haemodynamics in humans following caffeine consumption. Clin Exp Pharmacol Physiol. 2006 Apr;33(4):310-4. Abstract
95.	Selye, H. The stress of life. New York: McGraw-Hill, 1956. Amazon
96.	Larmande P, Hubert B, Sorabella A, Montigny E, Belin C, Gourdon D. [Influence of changes in climate and the calendar on the onset of a migraine crisis] Rev Neurol (Paris). 1996 Jan;152(1):38-43. Abstract
97.	Dohrman DP, Diamond I, Gordon AS. The role of the neuromodulator adenosine in alcohol's actions. Alcohol Health Res World. 1997;21(2):136-43. Abstract
98.	Hirsch AR. Olfaction in migraineurs. Headache. 1992 May;32(5):233-6. Abstract
99.	Kugler J, Laub M. Headache determination by meteorotropic influences. Res Clin Stud Headache. 1978;6:117-22. Abstract
100.	Wilkinson M, Woodrow J. Migraine and weather. Headache. 1979 Nov;19(7):375-8 Abstract
101.	Schulman J, Leviton A, Slack W, Porter D, Graham JR. The relationship of headache occurrence to barometric pressure. Int J Biometeorol. 1980 Sep;24(3):263-9. Abstract
102.	Nursall AS, Phillips DW. The effects of Weather on the Frequency and Severity of Migraine Headaches in Southwestern Ontario. Canadian Climate Centre Report 80-7 (unpublished manuscript, Environment Canada), Atmospheric Environment Service, Toronto 1980.
103.	Cull RE. Barometric pressure and other factors in migraine. Headache 1981 21:102-3. Article info
104.	Diamond S, Freitag F, Nursall A. The effects of weather on migraine frequency in Chicago. Headache Q. 1990;1:136-145. Complete article
105.	De Matteis G, Vellante M, Marrelli A, Villante U, Santalucia P, Tuzi P, Prencipe M. Geomagnetic activity, humidity, temperature and headache: is there any correlation? Headache. 1994 Jan;34(1):41-3. Abstract
106.	Piorecky J, Becker WJ, Rose MS. Effect of Chinook winds on the probability of migraine headache occurrence. Headache. 1997 Mar;37(3):153-8. Abstract
107.	Cooke LJ, Rose MS, Becker WJ. Chinook winds and migraine headache. Neurology. 2000 Jan 25;54(2):280-1. Abstract
108.	Vaitl D, Propson N, Stark R, Walter B, Schienle A. Headache and sferics. Headache. 2001 Oct;41(9):845-53. Abstract
109.	Walach H, Schweickhardt A, Bucher K. [Does weather modify headaches? An empirical evaluation of bio-weather categorization] Schmerz. 2002 Feb;16(1):1-8. Abstract
110.	Prince PB, Rapoport AM, Sheftell FD, Tepper SJ, Bigal ME. The effect of weather on headache. Headache. 2004 Jun;44(6):596-602. Abstract
111.	Villeneuve PJ, Szyszkowicz M, Stieb D, Bourque DA. Weather and emergency room visits for migraine headaches in Ottawa, Canada. Headache. 2006 Jan;46(1):64-72. Abstract
112.	Patient FAQs Migraine Headaches from WebMD Health with the Cleveland Clinic Medscape
113.	Nordenberg T. Heading Off Migraine Pain. FDA Consumer. 1993 May-Jun;32(3). www.fda.gov/fdac/features/1998/398_pain.html
114.	University of Michigan Health System website 2006 http://www.med.umich.edu/opm/newspage/2003/migraine.htm
115.	Diamond S. New advances in migraine diagnosis and treatment. US Doctor on the Internet. www.usdoctor.com
116.	Goasduff T, Dreano Y, Guillois B, Menez JF, Berthou F. Induction of liver and kidney CYP1A1/1A2 by caffeine in rat. Biochem Pharmacol. 1996 Dec 24;52(12):1915-9. Abstract
117.	Chen L, Bondoc FY, Lee MJ, Hussin AH, Thomas PE, Yang CS. Caffeine induces cytochrome P4501A2: induction of CYP1A2 by tea in rats. Drug Metab Dispos. 1996 May;24(5):529-33. Abstract
118.	Ayalogu EO, Snelling J, Lewis DF, Talwar S, Clifford MN, Ioannides C. Induction of hepatic CYP1A2 by the oral administration of caffeine to rats: lack of association with the Ah locus. Biochim Biophys Acta. 1995 Oct 17;1272(2):89-94. Abstract
119.	Faber MS, Fuhr U. Time response of cytochrome P450 1A2 activity on cessation of heavy smoking. Clin Pharmacol Ther. 2004 Aug;76(2):178-84. Abstract
120.	Stoica E, Enulescu O. Catecholamine response to exercise in migraine. Rom J Neurol Psychiatry. 1994 Jan-Mar;32(1):21-7. Abstract
121.	Newman EA. A purinergic dialogue between glia and neurons in the retina. Novartis Found Symp. 2006;276:193-202; discussion 202-7, 233-7, 275-81. Abstract
122.	Lee S, Hudson R, Kilpatrick K, Graham TE, Ross R. Caffeine ingestion is associated with reductions in glucose uptake independent of obesity and type 2 diabetes before and after exercise training. Diabetes Care. 2005 Mar;28(3):566-72. Abstract
123.	Silberstein SD. Shared mechanisms and comorbidities in neurologic and psychiatric disorders. Headache. 2001 Nov-Dec;41 Suppl 1:S117. Abstract
124.	Karaali-Savrun F, Goksan B, Yeni SN, Ertan S, Uzun N. Seizure-related headache in patients with epilepsy. Seizure. 2002 Jan;11(1):679. Abstract
125.	Ito M, Adachi N, Nakamura F, Koyama T, Okamura T, Kato M, Kanemoto K, Nakano T, Matsuura M, Hara S. Multi-center study on post-ictal headache in patients with localization-related epilepsy. Psychiatry Clin Neurosci. 2003 Aug;57(4):385-9. Clin Neurosci. 2003 Dec;57(6):613. Abstract
126.	Polosa R, Rorke S, Holgate ST. Evolving concepts on the value of adenosine hyperresponsiveness in asthma and chronic obstructive pulmonary disease. Thorax. 2002 Jul;57(7):649-54. Abstract
127.	Spicuzza L, Di Maria G, Polosa R. Adenosine in the airways: implications and applications. Eur J Pharmacol. 2006 Mar 8;533(1-3):7788. Abstract
128.	Agarwal AK, Shah A. Menstrual-linked asthma. J Asthma. 1997;34(6):539-45. Abstract
129.	Eliasson O, Scherzer HH, DeGraff AC Jr. Morbidity in asthma in relation to the menstrual cycle. J Allergy Clin Immunol. 1986 Jan;77(1 Pt 1):87-94. Abstract
130.	Dews PB, Curtis GL, Hanford KJ, O'Brien CP. The frequency of caffeine withdrawal in a population-based survey and in a controlled, blinded pilot experiment. J Clin Pharmacol. 1999 Dec;39(12):122132. Abstract
131.	Dews PB, O'Brien CP, Bergman J. Caffeine: behavioral effects of withdrawal and related issues. Food Chem Toxicol. 2002 Sep;40(9):1257-61. Abstract
132.	Silverman K, Evans SM, Strain EC, Griffiths RR. Withdrawal syndrome after the double-blind cessation of caffeine consumption. N Engl J Med. 1992 Oct 15;327(16):1109-14. Abstract
133.	Kaasinen V, Aalto S, Nagren K, Rinne JO. Expectation of caffeine induces dopaminergic responses in humans. Eur J Neurosci. 2004 Apr;19(8):2352-6. Abstract
134.	Juliano LM, Griffiths RR. A critical review of caffeine withdrawal: empirical validation of symptoms and signs, incidence, severity, and associated features. Psychopharmacology (Berl). 2004 Oct;176(1):129. Abstract
135.	Zeeberg P, Olesen J, Jensen R. Probable medication-overuse headache: the effect of a 2-month drug-free period. Neurology 2006 Jun 27;66(12):E43-4. Abstract
136.	Lipton RB, Stewart WF, Ryan Jr. RE, Saper J, Silberstein S, Fred Sheftell F. Efficacy and safety of acetaminophen, aspirin, and caffeine in alleviating migraine headache pain; three double-blind, randomized, placebo-controlled trials Arch Neurol. 1998;55:210-217. Abstract
137.	Crosson CE, DeBenedetto R, Gidday JM. Functional evidence for retinal adenosine receptors. J Ocul Pharmacol 1994;10(2):499-507. Abstract
138.	Kelman L. Migraine pain location: a tertiary care study of 1283 migraineurs. Headache. 2005 Sep;45(8):1038-47. Abstract Complete article
139.	When is a headache migraine? Interview with Dr. Richard B. Lipton dentalplans.com Women's Health Channel
140.	Hering-Hanit R, Gadoth N. Caffeine-induced headache in children and adolescents. Cephalalgia 2003;23:332-335. Abstract
141.	Eross E, Dodick D, Eross M. The Sinus, Allergy and Migraine Study (SAMS). Headache. 2007 Feb;47(2):213-24. Abstract
142.	Varani K, Portaluppi F, Merighi S, Ongini E, Belardinelli L, Borea PA. Caffeine Alters A2A Adenosine Receptors and Their Function in Human Platelets. Circulation.1999;99:2499-2502. Abstract Complete article
143.	Hohoff C, Marziniak M, Lesch KP, Deckert J, Sommer C, Mössner R. An adenosine A2A receptor gene haplotype is associated with migraine with aura. Cephalalgia. 27(2), 177-81. Abstract
144.	Kruuse C, Lassen LH, Iversen HK, Oestergaard S, Olesen J. Dipyridamole may induce migraine in patients with migraine without aura. Cephalalgia. 2006 Aug;26(8):925-33. Abstract
145.	Couch JR. Rebound-withdrawal headache (medication overuse headache). Curr Treat Options Neurol. 2006 Jan;8(1):11-9. Abstract
146.	Halldner L, Aden U, Dahlberg V, Johansson B, Ledent C, Fredholm BB. The adenosine A1 receptor contributes to the stimulatory, but not the inhibitory effect of caffeine on locomotion: a study in mice lacking adenosine A1 and/or A2A receptors. Neuropharmacology. 2004 Jun;46(7):1008-17. Abstract
147.	El Yacoubi M, Ledent C, Menard JF, Parmentier M, Costentin J, Vaugeois JM. The stimulant effects of caffeine on locomotor behaviour in mice are mediated through its blockade of adenosine A(2A) receptors. Br J Pharmacol. 2000 Apr;129(7):1465-73. Abstract
148.	Lydia A. Conlay LA, Conant JA, deBros F, Wurtman R. Caffeine alters plasma adenosine levels. Nature 1997 11 Sep;3891:136. Letter (PDF)
149.	Pedata F, Corsi C, Melani A, Bordoni F, Latini S. Adenosine extracellular brain concentrations and role of A2A receptors in ischemia. Ann N Y Acad Sci. 2001 Jun;939:74-84. Abstract
150.	Donnet A, Lanteri-Minet M, Guegan-Massardier E, Mick G, Fabre N, Geraud G, Lucas C, Navez M, Valade D. Chronic cluster headache: a French clinical descriptive study. J Neurol Neurosurg Psychiatry. 2007 Apr 18. Abstract
151.	Rhode A, Hosing V, Happe S, Biehl K, Young P, Evers S. Comorbidity of migraine and restless legs syndrome — a case-control study. Cephalalgia. 2007 Sep 21; [Epub ahead of print] Abstract
152.	Freeman M. Reconsidering the effects of monosodium glutamate: a literature review. J Am Acad Nurse Pract. 2006 Oct;18(10):482-6. Review. Abstract